Market Highlights
Global Sleep Apnea Device Market size is expected to have a market value of USD 7,683.72 Million by 2027.
In sleep apnea, a person's breathing is interrupted in sleep. Untreated sleep apnea can cause chronic disorders, such as high blood pressure, cardiovascular diseases, obesity, and neurological conditions.
Regional Analysis
Global Sleep Apnea Device Market, based on region, has been divided into the Americas, Europe, Asia-Pacific, and Middle East & Africa.
The Americas has been segmented into North America and Latin America, with the North America market further divided into the US and Canada. The Americas led the market and accounted for the largest share in 2019 due to a well-established healthcare system, rising number of patients with lung disease, and technological advancements in sleep apnea devices.
The European sleep apnea device market has been further segmented into Western Europe and Eastern Europe. The Western Europe Sleep Apnea Device market has further been classified into Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The presence of a vast patient pool in European countries and the number of market players involved in product launch and approval is expected to propel the demand for sleep apnea devices during the forecast period, thus fueling the market growth in the European region.
Key Players
MRFR recognizes the following companies as the Key Players in the global Sleep Apnea Device Market— Koninklijke Philips (Netherlands), ResMed (US), LivaNova (UK), Compumedics (Australia), Nihon Kohden (Japan), GE Healthcare (US), Natus Medica (US), BMC Medical (China), Cadwell (US), and Curative Medical (US).
https://www.marketresearchfuture.com/reports/sleep-apnea-devices-market-2061